Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update.


Journal

Modern rheumatology
ISSN: 1439-7609
Titre abrégé: Mod Rheumatol
Pays: England
ID NLM: 100959226

Informations de publication

Date de publication:
May 2020
Historique:
pubmed: 21 1 2020
medline: 3 10 2020
entrez: 21 1 2020
Statut: ppublish

Résumé

Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of 'Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 'consisting of a review of articles in the field and evidence-informed consensus-based experts' opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by 'Research on rare and intractable diseases, Health and Labor Sciences Research Grants'. This article is a digest version of the Japanese guidance.

Identifiants

pubmed: 31955618
doi: 10.1080/14397595.2020.1718866
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-423

Commentaires et corrections

Type : ErratumIn

Auteurs

Ichiro Kobayashi (I)

Center for Pediatric Allergy and Rheumatology, KKR Sapporo Medical Center, Sapporo, Japan.

Shinji Akioka (S)

Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Norimoto Kobayashi (N)

Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.

Naomi Iwata (N)

Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Japan.

Shunichiro Takezaki (S)

Department of Pediatrics, Hokkaido University Hospital, Sapporo, Japan.

Haruna Nakaseko (H)

Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Japan.

Satoshi Sato (S)

Division of Infectious Disease and Immunology, Saitama Children's Medical Center, Omiya, Japan.

Yutaka Nishida (Y)

Department of Pediatrics, School of Medicine, Gunma University, Maebashi, Japan.

Tomo Nozawa (T)

Department of Pediatrics, School of Medicine, Yokohama City University, Yokohama, Japan.

Yuichi Yamasaki (Y)

Department of Pediatrics, Kagoshima University Hospital, Kagoshima, Japan.

Kazuko Yamazaki (K)

Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.

Satoru Arai (S)

Department of Dermatology, St. Luke's International Hospital, Tokyo, Japan.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Masaaki Mori (M)

Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH